Jacqueline H. Stockley

R&d
Sunderland, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Reducing the Frequency of Follow-up Cystoscopy in Low-grade pTa Non-muscle-invasive Bladder Cancer Using the ADXBLADDER Biomarker.

Reducing the Frequency of Follow-up Cystoscopy in Low-grade pTa Non-muscle-invasive Bladder Cancer Using the ADXBLADDER Biomarker.

Journal: European urology focus

Published: October 28, 2021

Comparison of the performances of the ADXBLADDER test and urinary cytology in the follow-up of non-muscle-invasive bladder cancer: a blinded prospective multicentric study.

Comparison of the performances of the ADXBLADDER test and urinary cytology in the follow-up of non-muscle-invasive bladder cancer: a blinded prospective multicentric study.

Journal: BJU international

Published: August 04, 2020

Detection of MCM5 as a novel non-invasive aid for the diagnosis of endometrial and ovarian tumours.

Detection of MCM5 as a novel non-invasive aid for the diagnosis of endometrial and ovarian tumours.

Journal: BMC cancer

Published: May 02, 2020

Diagnostic Accuracy of MCM5 for the Detection of Recurrence in Nonmuscle Invasive Bladder Cancer Followup: A Blinded, Prospective Cohort, Multicenter European Study.

Diagnostic Accuracy of MCM5 for the Detection of Recurrence in Nonmuscle Invasive Bladder Cancer Followup: A Blinded, Prospective Cohort, Multicenter European Study.

Journal: The Journal of urology

Published: April 22, 2020

The RNA-binding protein Sam68 regulates expression and transcription function of the androgen receptor splice variant AR-V7.

The RNA-binding protein Sam68 regulates expression and transcription function of the androgen receptor splice variant AR-V7.

Journal: Scientific reports

Published: March 27, 2015

Feasibility study of a randomized controlled trial comparing docetaxel chemotherapy and androgen deprivation therapy with sequential prostatic biopsies from patients with advanced non-castration-resistant prostate cancer.

Feasibility study of a randomized controlled trial comparing docetaxel chemotherapy and androgen deprivation therapy with sequential prostatic biopsies from patients with advanced non-castration-resistant prostate cancer.

Journal: Urologic oncology

Published: February 20, 2015

The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer.

The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer.

Journal: Nucleic acids research

Published: December 10, 2014

Identification and Characterization of Novel Variations in Platelet G-Protein Coupled Receptor (GPCR) Genes in Patients Historically Diagnosed with Type 1 von Willebrand Disease.

Identification and Characterization of Novel Variations in Platelet G-Protein Coupled Receptor (GPCR) Genes in Patients Historically Diagnosed with Type 1 von Willebrand Disease.

Journal: PloS one

Published: November 26, 2014

Identification of a candidate prognostic gene signature by transcriptome analysis of matched pre- and post-treatment prostatic biopsies from patients with advanced prostate cancer.

Identification of a candidate prognostic gene signature by transcriptome analysis of matched pre- and post-treatment prostatic biopsies from patients with advanced prostate cancer.

Journal: BMC cancer

Published: August 26, 2014

The RNA-binding protein hnRNPA2 regulates β-catenin protein expression and is overexpressed in prostate cancer.

The RNA-binding protein hnRNPA2 regulates β-catenin protein expression and is overexpressed in prostate cancer.

Journal: RNA biology

Published: May 15, 2014

Oligodendrocyte progenitors: adult stem cells of the central nervous system?

Oligodendrocyte progenitors: adult stem cells of the central nervous system?

Journal: Experimental neurology

Published: April 23, 2014

A novel mutation in the P2Y12 receptor and a function-reducing polymorphism in protease-activated receptor 1 in a patient with chronic bleeding.

A novel mutation in the P2Y12 receptor and a function-reducing polymorphism in protease-activated receptor 1 in a patient with chronic bleeding.

Journal: Journal of thrombosis and haemostasis : JTH

Published: October 17, 2013

Showing 1-12 of 17

Last Updated: 09/26/2026